Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus?
dc.contributor.author | Hayward, Rodney A. | en_US |
dc.contributor.author | Vijan, Sandeep | en_US |
dc.contributor.author | Kent, D. M. | en_US |
dc.date.accessioned | 2006-09-08T19:44:44Z | |
dc.date.available | 2006-09-08T19:44:44Z | |
dc.date.issued | 2000-01 | en_US |
dc.identifier.citation | Vijan, S.; Kent, D. M.; Hayward, R. A.; (2000). "Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus?." Diabetologia 43(1): 125-130. <http://hdl.handle.net/2027.42/41888> | en_US |
dc.identifier.issn | 0012-186X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41888 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10672454&dopt=citation | en_US |
dc.description.abstract | Randomized controlled trials (RCTs) are often considered the standard for defining the practice of evidence-based medicine. Taken alone, they are, however, often insufficient to guide clinical care. Randomized controlled trials are clearly the best method to determine whether interventions are efficacious. They have, however, numerous limitations which make them difficult to carry out or limit applicability to routine clinical practice. Although observational studies also have inherent limitations, they provide data which can help to further explain the results of randomized controlled trials. The use of observational studies to frame randomized trials can allow better application of randomized controlled trial results to individual patients and can thus help to optimize delivery of care, inform clinical practice and determine the need for further such trials. | en_US |
dc.format.extent | 69073 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Springer-Verlag Berlin Heidelberg | en_US |
dc.subject.other | Legacy | en_US |
dc.title | Are randomized controlled trials sufficient evidence to guide clinical practice in Type II (non-insulin-dependent) diabetes mellitus? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | The Robert Wood Johnson Clinical Scholars Program, University of Michigan, USA, US, | en_US |
dc.contributor.affiliationother | The Veterans Affairs Center for Practice Management and Outcomes Research, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationother | The Veterans Affairs Center for Practice Management and Outcomes Research, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 10672454 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41888/1/125-43-1-125_00430125.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s001250050017 | en_US |
dc.identifier.source | Diabetologia | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.